Found: 16
Select item for more details and to access through your institution.
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Relapsing antibody-negative patients with features of neuromyelitis optica spectrum disorders: Differences in N -acetylaspartate level in the cervical spinal cord indicate distinct underlying processes.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2221, doi. 10.1177/13524585221115304
- By:
- Publication type:
- Article
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 2, p. 217, doi. 10.1177/13524585211018987
- By:
- Publication type:
- Article
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 968, doi. 10.1177/1352458520943777
- By:
- Publication type:
- Article
Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD – No.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 15, doi. 10.1177/1352458520958599
- By:
- Publication type:
- Article
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
- Published in:
- Acta Neuropathologica Communications, 2017, v. 5, p. 1, doi. 10.1186/s40478-017-0495-8
- By:
- Publication type:
- Article
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 2, p. 143, doi. 10.1001/jamaneurol.2023.4737
- By:
- Publication type:
- Article
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 4, p. 478, doi. 10.1001/jamaneurol.2017.4601
- By:
- Publication type:
- Article
Immune regulation of multiple sclerosis by transdermally applied myelin peptides.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 5, p. 593, doi. 10.1002/ana.22219
- By:
- Publication type:
- Article
Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 1, p. 269, doi. 10.1007/s00415-021-10619-1
- By:
- Publication type:
- Article
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 1, p. 140, doi. 10.1007/s00415-015-7952-8
- By:
- Publication type:
- Article
Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2022, v. 56, n. 3, p. 210, doi. 10.5603/PJNNS.a2021.0077
- By:
- Publication type:
- Article
Double-negative neuromyelitis optica spectrum disorder.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 11/12, p. 1353, doi. 10.1177/13524585231199819
- By:
- Publication type:
- Article
Mitochondrial diseases mimicking NMOSD.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 897, doi. 10.1177/13524585231172944
- By:
- Publication type:
- Article